These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
647 related articles for article (PubMed ID: 4915546)
1. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases]. Velasco M; Losada M; Losada A; Ramirez G Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546 [No Abstract] [Full Text] [Related]
2. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases. Miyawaki S; Ritchie RF J Immunol; 1974 Oct; 113(4):1346-52. PubMed ID: 4606613 [No Abstract] [Full Text] [Related]
3. Variable reactivity of antinuclear immunoglobulins with cell nuclei of various origin and quality. Zitńan D; Cebecauer L J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):303-12. PubMed ID: 4921006 [No Abstract] [Full Text] [Related]
4. The serology of connective tissue disorders. Holborow EJ Br J Hosp Med; 1978 Mar; 19(3):250, 252, 257-8. PubMed ID: 343858 [No Abstract] [Full Text] [Related]
5. [Determination of the immunoglobulin type of complement fixing and non-fixing anti-nuclear factors]. Peltier AP; Strejcek G Rev Fr Etud Clin Biol; 1969 Oct; 14(8):787-95. PubMed ID: 4189485 [No Abstract] [Full Text] [Related]
6. [Detection of antinuclear factors in rheumatic diseases]. Ménard HA; Myhal D; Camerlain M; Lussier A Union Med Can; 1974 Apr; 103(4):722-6. PubMed ID: 4601283 [No Abstract] [Full Text] [Related]
7. Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases. Parker MD; Kerby GP Ann Rheum Dis; 1974 Sep; 33(5):465-72. PubMed ID: 4608364 [No Abstract] [Full Text] [Related]
8. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases. Diaz Gill GA; Beutner EH; Eisenberg RB Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867 [No Abstract] [Full Text] [Related]
9. Antinuclear antibodies in some internal diseases, especially autoimmunization diseases. Lange A Arch Immunol Ther Exp (Warsz); 1972; 20(2):209-26. PubMed ID: 4112512 [No Abstract] [Full Text] [Related]
10. [Comparative studies of the demonstration of antinuclear factors by immunofluorescence and antiglobulin consumption tests]. Schmidt K; Mueller-Eckhardt C; Becker W Verh Dtsch Ges Rheumatol; 1969; 1():251-8. PubMed ID: 4934585 [No Abstract] [Full Text] [Related]
11. [Allergy and collagen diseases]. Horiuchi Y; Hirose S Naika; 1972; 29(1):83-9. PubMed ID: 4622138 [No Abstract] [Full Text] [Related]
13. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis. Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657 [TBL] [Abstract][Full Text] [Related]
14. The immunofluorescent "band" test in mixed connective tissue disease. Levitin PM; Weary PE; Giuliano VJ Ann Intern Med; 1975 Jul; 83(1):53-5. PubMed ID: 1096702 [TBL] [Abstract][Full Text] [Related]
15. [Optic immunofluorescence demonstration of monoclonal and polyclonal antinuclear antibodies (ANA) in rheumatoid arthritis (RA) and lupus erythematosus disseminatus (LED)]. Dreher R; Helmke K Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():808-13. PubMed ID: 417508 [No Abstract] [Full Text] [Related]
16. Antinucleolar antibodies. Their frequency and diagnostic association. Ritchie RF N Engl J Med; 1970 May; 282(21):1174-8. PubMed ID: 4909324 [No Abstract] [Full Text] [Related]
17. Pathogenesis of connective tissue disease. Holborow EJ Trans Ophthalmol Soc U K (1962); 1974 Sep; 94(3):712-20. PubMed ID: 4282889 [No Abstract] [Full Text] [Related]
18. [Immunofluorescent appearance of antinuclear antibodies and LE cells in connective tissue diseases]. Kolarzowska B Pol Tyg Lek; 1970 Jan; 25(1):9-12. PubMed ID: 4189987 [No Abstract] [Full Text] [Related]
19. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis]. Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175 [No Abstract] [Full Text] [Related]
20. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases]. Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516 [No Abstract] [Full Text] [Related] [Next] [New Search]